ORIC
NASDAQ · Biotechnology
Oric Pharmaceuticals Inc
$13.50
+0.57 (+4.41%)
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Price Target
Analyst Price Target
+287.1% upside
Low Target
$31.55
Average Target
$52.26
High Target
$71.26
Current Price
$13.50
Current
$13.50
$13.50
Target
$52.26
$52.26
$31.55
$52.26 avg
$71.26
Scenario Analysis
Bear Case
$31.55
133.7%
Low target
Base Case
$52.26
+287.1%
Avg target
Bull Case
$71.26
+427.9%
High target
Risk/Reward
3.2x
Highly favorable
Price in Context
52-Week High
$14.93
-9.6% from high
52-Week Low
$7.23
+86.7% from low
Target vs 52W High
$52.26
+250.0% vs high
Next Earnings Report
Aug 10, 2026
Today
EPS Est: $-0.37
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -11.6% |
| REGN | Buy | 37 | 70% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.0% |